NCT02979678

Brief Summary

The purpose of this study is to update the EORTC QLQ Breast (BR)-23 Module. Since the development of BR-23 published 1996 the standard therapy of breast cancer has changed. New therapies brought new side effects and different impact on QoL (quality of life) are not sufficiently covered by EORTC QLQ BR-23 and an update of the module could be useful, both from clinical and scientific point of view.

Trial Health

50
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
260

participants targeted

Target at P75+ for not_applicable quality-of-life

Timeline
Completed

Started Jun 2015

Longer than P75 for not_applicable quality-of-life

Geographic Reach
8 countries

9 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2015

Completed
1.4 years until next milestone

First Submitted

Initial submission to the registry

October 13, 2016

Completed
2 months until next milestone

First Posted

Study publicly available on registry

December 1, 2016

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2018

Completed
1.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2019

Completed
Last Updated

September 6, 2017

Status Verified

September 1, 2017

Enrollment Period

2.8 years

First QC Date

October 13, 2016

Last Update Submit

September 5, 2017

Conditions

Keywords

Breast cancer, quality of life

Outcome Measures

Primary Outcomes (1)

  • Quality of life

    Patients under Treatment are asked to complete the questionnaire

    3 years, Patients under treatment are asked once to complete the questionnaire during 3 years

Study Arms (1)

Questionnaire

EXPERIMENTAL

Breast cancer

Other: Questionnaire

Interventions

The questionnaire should be updated with respect to wording, terminology.

Also known as: EORTC QLQ-Breast Cancer Module Update
Questionnaire

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with early or metastatic breast cancer

You may not qualify if:

  • Patients with second malignancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (9)

Medical University Graz

Graz, Austria

RECRUITING

University Hospital Centre Rijeka

Rijeka, Croatia

RECRUITING

Institut de Cancerologie de Lorraine

Lorraine, France

RECRUITING

University Medical Center Regensburg

Regensburg, Germany

RECRUITING

Instituto Nazionale Tumori Fondazione Pascale

Naples, Italy

RECRUITING

IOV Oncologico Veneto Padova

Padivarma, Italy

RECRUITING

Netherlands Cancer Institute - NKI

Amsterdam, Netherlands

RECRUITING

Jagiellonian University Medical College Krakow

Krakow, Poland

RECRUITING

Oncology Department Hospital of Navarre

Navarra, Spain

RECRUITING

Related Publications (2)

  • Sprangers MA, Groenvold M, Arraras JI, Franklin J, te Velde A, Muller M, Franzini L, Williams A, de Haes HC, Hopwood P, Cull A, Aaronson NK. The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study. J Clin Oncol. 1996 Oct;14(10):2756-68. doi: 10.1200/JCO.1996.14.10.2756.

  • Johnson C, Aaronson N, Blazeby JM et al. Guidelines for Developing Questionnaire Modules. 4ed.Bruessels, EORTC,2011

    RESULT

MeSH Terms

Conditions

Breast Neoplasms

Interventions

Surveys and Questionnaires

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • Vesna Bjelic-Radisic

    Medical University of Graz

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 13, 2016

First Posted

December 1, 2016

Study Start

June 1, 2015

Primary Completion

March 1, 2018

Study Completion

June 1, 2019

Last Updated

September 6, 2017

Record last verified: 2017-09

Data Sharing

IPD Sharing
Will not share

Locations